Study of a new skin imaging tool for cancer diagnosis
Part of Cancer clinical trials.
This study is looking at how well a new skin imaging tool called LC-OCT works in everyday skin cancer clinics in the Netherlands. It will help doctors understand if this tool can accurately identify skin cancers without needing as many biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to have had a special skin imaging test called LC-OCT during a skin cancer (Mohs) clinic visit in the Netherlands between January and June 2025.
- Your diagnosis must be confirmed by a skin tissue sample (biopsy) or surgical removal, or you must have a follow-up check-up 6 to 12 months later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new imaging methods to look at basal cell carcinoma, a common type of skin cancer, when you're already getting it treated. The goal is to see how well these imaging tools work in a real clinic setting, which may help improve how skin cancer is assessed in the future.
This trial uses a special microscope to look at skin biopsy samples in new ways. It may help doctors understand skin conditions better without needing extra procedures.
This study tests an AI-enhanced imaging technique to help doctors see the edges of a common type of skin cancer called basal cell carcinoma before surgery. It may help ensure the cancer is removed completely the first time.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This study is testing whether a special type of scan (called D-OCT) can accurately detect and classify a common type of skin cancer called basal cell carcinoma. The goal is to see if this scan can diagnose the cancer without needing a biopsy.
Hear when a new Basal Cell Carcinoma of Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.